Stephen Doster
-
Biologists discover signaling pathways potentially associated with pancreatic cancer
Kathleen DelGiorno, assistant professor of cell and developmental biology, her lab and collaborators at the Salk Institute have discovered some of the specific signaling molecules involved in tumor progression in pancreatic cancer. These molecules, called eicosanoids, play a role in inflammation and… Read MoreApr. 1, 2022
-
Vanderbilt ranks 12th in annual survey of NIH funding; 2021 awards topped $445M
Vanderbilt University again ranked among the nation’s top research institutions receiving funding from the National Institutes of Health, according to the latest data compiled by the Blue Ridge Institute for Medical Research. The total amount Vanderbilt scholars received across the School of… Read MoreApr. 1, 2022
-
Crowe receives national award for COVID antibody research
James Crowe Jr., MD, director of the Vanderbilt Vaccine Center, and Michel Nussenzweig, MD, PhD, of The Rockefeller University, have been jointly awarded the 2022 Harrington Prize for Innovation in Medicine for “groundbreaking work” that enabled the use of human antibodies to treat COVID-19. The announcement was made… Read MoreApr. 1, 2022
-
Biochemical technique for finding small molecules discovered by Vanderbilt and University of Virginia researchers
Lipid rafts, a component of the plasma membranes that surround all cells in the human body, are essential in regulating the membranes’ structure, among other functions. But they are hard to study because traditional biochemical methods tend to destroy them. Chuck Sanders, associate dean for research,… Read MoreMar. 28, 2022
-
Hunger signals, including those from cannabinoids, mapped in the brain
Cannabis is well-known for having an effect on eating behaviors. However, how the natural cannabinoid molecules found in the body regulate feeding and eating is not well researched. Masoud Ghamari-Langroudi, research assistant professor of molecular physiology and biophysics, research assistant professor of pharmacology and faculty affiliate… Read MoreMar. 25, 2022
-
Pietenpol named AACR Fellow
The American Association for Cancer Research (AACR) has inducted Jennifer Pietenpol, PhD, and Yu Shyr, PhD, into the 2022 class of Fellows of the AACR Academy. The mission of the AACR Academy is to recognize and honor distinguished scientists whose scientific contributions have propelled significant innovation and progress against cancer. Read MoreMar. 24, 2022
-
Improving insulin sensitivity
By Wendy Bindeman Ambra Pozzi Ambra Pozzi, professor of medicine and of molecular physiology and biophysics, first author Kakali Ghoshal (a postdoc in the Pozzi lab), and colleagues recently published a study showing that supplementation with an analog of a lipid metabolite called epoxyeicosatrienoic acid, which is involved in insulin… Read MoreMar. 15, 2022
-
Kimberly Newsom in Pietenpol lab honored with Research Staff Award
Laboratory and administrative personnel at Vanderbilt University Medical Center were honored March 4 for research excellence during the 18th annual Research Staff Awards Ceremony at the Aertson Hotel in Nashville. Jennifer Pietenpol, PhD, director of the Vanderbilt-Ingram Cancer Center and VUMC’s Executive Vice President for Research, and Lawrence Marnett, PhD,… Read MoreMar. 10, 2022
-
Wikswo and VIIBRE team on track to build third-generation ‘self-driving lab’ with $1M from National Science Foundation
John Wikswo, founder and director of the Vanderbilt Institute for Integrative Biosystems Research and Education and Gordon A. Cain University Professor, is the principal investigator of a $1 million award from the National Science Foundation. The object is to build a pathbreaking… Read MoreMar. 10, 2022
-
Probing cancer cell invasion
Cancer cells metastasize, or spread to different parts of the body, by escaping from a primary tumor and invading neighboring tissues. To penetrate normal tissue barriers, migrating cancer cells form membrane protrusions called invadopodia that degrade the surrounding extracellular matrix (ECM). Aron Parekh, PhD, and colleagues… Read MoreMar. 3, 2022